Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review

J Surg Oncol. 2014 Aug;110(2):182-96. doi: 10.1002/jso.23619. Epub 2014 Apr 24.

Abstract

The liver is the most common visceral site of colorectal cancer metastasis and recurrence. Given that only 25% of patients with colorectal liver metastases are amenable to curative surgical resection at initial diagnosis, locoregional intra-arterial therapies including hepatic arterial infusion chemotherapy, conventional transarterial chemoembolization, drug-eluting-bead transarterial chemoembolization, and radioembolization have increasingly developed as viable treatment options. The rationale, efficacy, safety, and toxicity of each of these therapies are reviewed and stratified based on current evidence.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms / pathology*
  • Embolization, Therapeutic / adverse effects
  • Embolization, Therapeutic / methods*
  • Hepatic Artery
  • Humans
  • Infusions, Intra-Arterial* / adverse effects
  • Liver Neoplasms / mortality
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy*
  • Neoadjuvant Therapy
  • Treatment Outcome

Substances

  • Antineoplastic Agents